Replies to post #149741 on Biotech Values

[jq1234]

Yes, I still have my full position in TSRX, CLDX, BMRN. TSRX should report second ph3 trial result early next year; CLDX should report survival data from CDX011 in Dec, BMRN should report GALNS ph3 result in Nov. These should be important events for these companies.